vTv Therapeutics (VTVT) Tops Q1 EPS by 5c

vTv Therapeutics (NASDAQ: VTVT) reported Q1 EPS of ($0.06), $0.05 better than the analyst estimate of ($0.11).

For earnings history and earnings-related data on vTv Therapeutics (VTVT) click here.

You May Also Be Interested In

• Blue Owl leads $2.4 billion debt deal for Iren data center
• NewtekOne cuts EPS guidance, shifts focus to net interest income
• Jiayin Group (JFIN) Reports Q2 Loss of RMB3.56